You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BORTEZOMIB (VELCADE)

Showing 1 - 25 of 910
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

Active, not recruiting
Has Results
  • Waldenstrom's Macroglobulinemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Diffuse Large B Cell Lymphoma Trial in Berlin (Ibrutinib and Bortezomib + R-CHOP)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Ibrutinib and Bortezomib + R-CHOP
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin, Hematology, Oncology and T
Aug 10, 2022

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 10, 2023

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Multiple Myeloma Trial in Atlanta (Bortezomib, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Nov 1, 2021

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade

Active, not recruiting
  • Multiple Myeloma
  • velcade subcutaneous melphalan prednisone
  • +2 more
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bortezomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 4, 2022

Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

Active, not recruiting
  • Multiple Myeloma
  • High-Risk Cancer
  • Bortezomib following nonmyeloablative allogeneic transplant
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Aug 22, 2022

Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
Dec 3, 2021

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Jacksonville, Florida
  • +1 more
Jan 5, 2023

Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Auto Stem Cell Transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022

Multiple Myeloma Based on Multi-omics

Enrolling by invitation
  • Multiple Myeloma
  • Bortezomib
  • Beijing, China
    Beijng Chao Yang Hospital
Apr 21, 2022

Lymphoma, Mantle Cell, Mantle Cell Lymphoma Trial run by the NCI (Rituximab (R), EPOCH, Bortezomib (B))

Active, not recruiting
Has Results
  • Lymphoma, Mantle Cell
  • Mantle Cell Lymphoma
  • Rituximab (R)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 21, 2021

Antibody-mediated Rejection Trial in Tehran (Bortezomib)

Recruiting
  • Antibody-mediated Rejection
  • Tehran, Iran, Islamic Republic of
    SBMU
Jan 27, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

Terminated
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 22, 2021

Subcutaneous Velcade at Home of Patients With Myeloma.

Recruiting
  • Multiple Myeloma
  • Odense, Denmark
    Odense University Hospital
Dec 17, 2021

Multiple Myeloma Trial in Hackensack (Fludarabine monophosphate, melphalan, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • Fludarabine monophosphate, melphalan, Bortezomib
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Apr 29, 2022

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, velcade, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +12 more
Aug 25, 2021

Lymphoma Trial in Duarte, South Pasadena (biological, drug, other)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +3 more
  • Duarte, California
  • +1 more
Feb 28, 2022

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022